Autres langues Hana Pharm Co., Ltd.

Actions

A293480

KR7293480000

Cours en clôture Korea S.E. Autres places de cotation 00:00:00 21/05/2024			Varia. 5j.	Varia. 1 janv.
13 010 ^KRW	-1,36 %		-1,14 %	-6,74 %

2023	Les actions de Singapour reviennent dans le vert ; Hyphens Pharma augmente de 5% grâce à un accord pour développer un médicament de sédation à Singapour	MT
2023	Hyphens Pharma va développer et commercialiser le médicament sédatif de Hana Pharm à Singapour	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Singapore Shares Return to Green; Hyphens Pharma Rises 5% on Deal to Develop Sedation Drug in Singapore	18/05/23
Hyphens Pharma to Develop, Commercialize Hana Pharm's Sedation Drug in Singapore	18/05/23
Hyphens Pharma Pte. Ltd. Signs an Exclusive Sub-License and Supply Agreement with Hana Pharm Co., Ltd. to Develop and Commercialise Byfavo® 20mg in Singapore	17/05/23
Eight South Korean Firms to Donate $2.4 Million Worth of Medicine to Ukraine	12/04/22
Hana Pharm Receives Market Approval for Byfavo (Remimazolam) in Procedural Sedation in South Korea	31/08/21
Hana Pharm Informs PAION AG About the Launch of Byfavo™ (Remimazolam) for the Use in General Anesthesia in South Korea	07/04/21
Hana Pharm Co., Ltd's Equity Buyback announced on August 19, 2019, has expired.	18/02/20
Tranche Update on Hana Pharm Co., Ltd's Equity Buyback Plan announced on August 6, 2019.	05/02/20
Tranche Update on Hana Pharm Co., Ltd's Equity Buyback Plan announced on August 6, 2019.	05/02/20
Tranche Update on Hana Pharm Co., Ltd's Equity Buyback Plan announced on August 6, 2019.	05/02/20
Hana Pharm Co., Ltd's Equity Buyback announced on August 6, 2019, has expired with 87,239 shares, representing 0.54% for KRW 1,997.13 million.	05/02/20
Tranche Update on Hana Pharm Co., Ltd's Equity Buyback Plan announced on July 9, 2019.	08/01/20
Hana Pharm Co., Ltd's Equity Buyback announced on July 9, 2019, has expired.	08/01/20
Tranche Update on Hana Pharm Co., Ltd's Equity Buyback Plan announced on July 26, 2019.	30/10/19
Hana Pharm Co., Ltd's Equity Buyback announced on July 26, 2019, has expired with 84,312 shares, representing 0.53% for KRW 1,997.08 million.	30/10/19
Hana Pharm Co., Ltd announces an Equity Buyback for KRW 1,000 million worth of its shares.	19/08/19
Hana Pharm Co., Ltd authorizes a Buyback Plan.	19/08/19
Hana Pharm Co., Ltd announces an Equity Buyback for KRW 2,000 million worth of its shares.	06/08/19
Hana Pharm Co., Ltd authorizes a Buyback Plan.	06/08/19
Hana Pharm Co., Ltd announces an Equity Buyback for KRW 2,000 million worth of its shares.	26/07/19

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Hana Pharm Co., Ltd.

Actions

A293480

KR7293480000

Autres langues

Filtres